These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2714145

  • 21. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
    Pørksen N, Grøfte B, Nyholm B, Holst JJ, Pincus SM, Veldhuis JD, Schmitz O, Butler PC.
    Diabetes; 1998 Jan; 47(1):45-9. PubMed ID: 9421373
    [Abstract] [Full Text] [Related]

  • 22. Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM.
    Dupre J, Behme MT, Hramiak IM, McFarlane P, Williamson MP, Zabel P, McDonald TJ.
    Diabetes; 1995 Jun; 44(6):626-30. PubMed ID: 7789625
    [Abstract] [Full Text] [Related]

  • 23. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
    Chelikani PK, Haver AC, Reidelberger RD.
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A liquid mixed meal or exogenous glucagon-like peptide 1 (GLP-1) do not alter plasma leptin concentrations in healthy volunteers.
    Drewes C, Nauck MA, Horn R, Holst J, Schmiegel W, Brabant G.
    Acta Diabetol; 1997 Oct; 34(3):230-4. PubMed ID: 9401646
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
    Prigeon RL, Quddusi S, Paty B, D'Alessio DA.
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E701-7. PubMed ID: 12773303
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
    Larsen PJ, Vrang N, Tang-Christensen M.
    Curr Pharm Des; 2003 Oct; 9(17):1373-82. PubMed ID: 12769729
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.
    Long SJ, Sutton JA, Amaee WB, Giouvanoudi A, Spyrou NM, Rogers PJ, Morgan LM.
    Br J Nutr; 1999 Apr; 81(4):273-9. PubMed ID: 10999014
    [Abstract] [Full Text] [Related]

  • 34. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [Abstract] [Full Text] [Related]

  • 35. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat.
    Bozkurt A, Näslund E, Holst JJ, Hellström PM.
    Regul Pept; 2002 Jul 15; 107(1-3):129-35. PubMed ID: 12137975
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
    Toft-Nielson M, Madsbad S, Holst JJ.
    Diabetes; 1996 May 15; 45(5):552-6. PubMed ID: 8621002
    [Abstract] [Full Text] [Related]

  • 38. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
    Gutniak MK, Linde B, Holst JJ, Efendić S.
    Diabetes Care; 1994 Sep 15; 17(9):1039-44. PubMed ID: 7988303
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Glucagon-like peptide-1: a potent regulator of food intake in humans.
    Gutzwiller JP, Göke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C.
    Gut; 1999 Jan 15; 44(1):81-6. PubMed ID: 9862830
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.